CCO[C@@H]1OC(C(=O)N2CCCCCCC2)=C[C@H](c2ccc(C(F)(F)F)cc2)[C@H]1CCCO
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?